
Neoadjuvant immunotherapy may improve outcomes in high-risk breast cancer
March 31, 2025 3 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The addition of nivolumab to …